Thiophene based oligomers as light activated biocides
US-9125415-B2 · Sep 8, 2015 · US
US9750250B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9750250-B2 |
| Application number | US-201615018179-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 8, 2016 |
| Priority date | Jan 14, 2015 |
| Publication date | Sep 5, 2017 |
| Grant date | Sep 5, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Various embodiments disclosed relate to conjugated polyelectrolytes and methods of using the same. Various embodiments provide a conjugated polyelectrolyte including a subunit having the structure —R 1 —Y—R 2 —Z—. At each occurrence, R 1 is independently chosen from 1,4-bonded phenylene substituted by —X—R 3 —R 4 j times and 2,5-bonded thiophene substituted by —X—R 3 —R 4 j times. At each occurrence, Y is independently chosen from a bond and —C≡C—. At each occurrence, R 2 is independently chosen from a bond, a substituted or unsubstituted phenylene, thiophenylene, azulenylene, heptalenylene, biphenylene, indacenylene, fluorenylene, phenanthrenylene, triphenylenylene, pyrenylene, naphthacenylene, chrysenylene, biphenylenylene, anthracenylene, and naphthylene. At each occurrence, Z is independently chosen from a bond and —C≡C—. The variables j, R 3 , and R 4 are as defined herein.
Opening claim text (preview).
What is claimed is: 1. An antimicrobial substrate, the antimicrobial substrate comprising: a substrate; and a conjugated polyelectrolyte comprising a subunit having the following structure: wherein at each occurrence, R 1 has the structure: at each occurrence, X is a bond, —O—, —NH—, or —S—, at each occurrence, R 3 is a (C 1 -C 20 )hydrocarbylene interrupted by 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9 heteroatoms, at each occurrence, R 5 is independently chosen from a substituted or unsubstituted (C 1 -C 10 )hydrocarbyl, at each occurrence, Y is independently chosen from a bond and —C≡C—, at each occurrence, R 2 is independently chosen from a bond, a substituted or unsubstituted phenylene, thiophenylene, azulenylene, heptalenylene, biphenylene, indacenylene, fluorenylene, phenanthrenylene, triphenylenylene, pyrenylene, naphthacenylene, chrysenylene, biphenylenylene, anthracenylene, and naphthylene, and at each occurrence, Z is independently chosen from a bond and —C≡C—. 2. The antimicrobial substrate of claim 1 , wherein in the substrate is chosen from a wipe, a tissue, a bandage, a medical device, surgical instrument, warfighter machinery, a sponge, a textile, a diaper, a counter-top, a food preparation surface, a wound dressing, a dressing for surgical incisions, a keyboard surface, a packing for wounds, a packing for surgical incisions, a nasal packing, and a feminine care product. 3. The antimicrobial substrate of claim 1 , wherein the conjugated polyelectrolyte comprises terminal groups independently chosen from —H, -L-H, -L-C≡CH, -L-C≡CH, -L-R T , -L-R L —R T , -L-C≡C—R T , -L-C≡C—R L —R T , and -L-R L —C≡C—R L —R T , -L-C≡C—R L —C≡C—R L —R T , wherein at each occurrence, R T is independently chosen from —H, —Br, —(C 1 -C 10 )alkyl, —C(O)—OH, —C(O)—O((C 1 -C 10 )alkyl), —(C 1 -C 10 )alkylene-N((C 1 -C 10 )alkyl) 3 + X − , —O—(C 1 -C 10 )alkylene-N((C 1 -C 10 )alkyl) 3 + X − , wherein X − is a counterion, at each occurrence, R L is independently chosen from a substituted or unsubstituted phenylene, thiophenylene, azulenylene, heptalenylene, biphenylene, indacenylene, fluorenylene, phenanthrenylene, triphenylenylene, pyrenylene, naphthacenylene, chrysenylene, biphenylenylene, anthracenylene, naphthylene, and -(1,4-substituted 1,4-diazabicyclo[2.2.2]octane-1,4-diium)-, and at each occurrence, L is independently chosen from a bond, —(C 1 -C 10 )alkylene-, and —O—(C 1 -C 10 )alkylene-. 4. The antimicrobial substrate of claim 1 , wherein at each occurrence, X is —O—, at each occurrence, R 3 is a (C 2 -C 4 )akylene, at each occurrence, Y is —C≡C—, at each occurrence, R 2 is a bond, and at each occurrence, Z is a bond. 5. The antimicrobial substrate of claim 1 , wherein at each occurrence, X is —O—, at each occurrence, R 3 is a (C 1 -C 10 )alkylene interrupted by 0, 1, 2, 3, or 4 oxygen atoms, at each occurrence, R 5 is independently chosen from a (C 1 -C 5 )alkyl, at each occurrence, Y is —C≡C—, at each occurrence, R 2 is a bond, and at each occurrence, Z is a bond. 6. The antimicrobial substrate of claim 1 , wherein at each occurrence, X is —O—, at each occurrence, R 3 is a (C 2 -C 4 )alkylene, at each occurrence, Y is —C≡C—, at each occurrence, R 2 is independently chosen from a 1,4-substituted phenylene and a 2,5-substituted thiophenylene, and at each occurrence, Z is a —C≡C—. 7. The antimicrobial substrate of claim 1 , wherein at each occurrence, X is —O—, at each occurrence, R 3 is a (C 1 -C 10 )alkylene interrupted 0, 1, 3, or 4 oxygen atoms, at each occurrence, R 5 is independently (C 1 -C 5 )alkyl, at each occurrence, Y is —C≡C—, at each occurrence, R 2 is a phenylene, and at each occurrence, Z is a —C≡C—. 8. The antimicrobial substrate of claim 1 , wherein the conjugated polyelectrolyte is non-leachably bound to the substrate. 9. The antimicrobial substrate of claim 1 , wherein the antimicrobial substrate exhibits antimicrobial properties comprising prevention of growth of at least one of Gram-positive Staphylococcus aureus , Gram-negative Pseudomonas aeruginosa , and Escherichia coli , wherein the antimicrobial properties of the antimicrobial substrate exceed the antimicrobial properties of a corresponding substrate without the antimicrobial compound. 10. An antimicrobial substrate, the antimicrobial substrate comprising: a substrate; and a conjugated polyelectrolyte comprising a subunit having the following structure: wherein at each occurrence, R 1 is independently chosen from: at each occurrence, X is —O—, —NH—, or —S—, at each occurrence, R 3 is a (C 1 -C 20 )hydrocarbylene interrupted by 0, 1, 2, 3, 4, 5, 6, 7, 8, or 9 heteroatoms, at each occurrence, R 4 is independently chosen from —H, —R 5 , -(1,4-substituted 1,4-diazabicyclo[2.2.2]octane-1,4-diium)-R 5 , 3-R 5 -substituted imidazolium, pyridinium, —SO 3 − , —CO 2 H, —CO 2 − , —N + (R 5 ) 3 , and —N(R 5 ) 2 , at each occurrence, R 5 is independently chosen from a substituted or unsubstituted (C 1 -C 10 )hydrocarbyl, at each occurrence, Y is independently chosen from a bond and —C≡C—, at each occurrence, R 2 is a bond, and at each occurrence, Z is a bond. 11. The antimicrobial substrate of claim 10 , wherein in the substrate is chosen from a wipe, a tissue, a bandage, a medical device, surgical instrument, warfighter machinery, a sponge, a textile, a diaper, a counter-top, a food preparation surface, a wound dressing, a dressing for surgical incisions, a keyboard surface, a packing for wounds, a packing for surgical incisions, a nasal packing, and a feminine care product. 12. The antimicrobial substrate of claim 10 , wherein the conjugated polyelectrolyte comprises terminal groups independently chosen from —H, -L-H, -L-C≡CH, -L-R T , -L-R L —R T , -L-C≡C—R T , -L-C≡C—R L —R T , and -L-R L —C≡C—R L —R T , -L-C≡C—R L —C≡C—R L —R T , wherein at each occurrence, R T is independently chosen from —H, —Br, —(C 1 -C 10 )alkyl, —C(O)—OH, —C(O)—O((C 1 -C 10 )alkyl), —(C 1 -C 10 )alkylene-N((C 1 -C 10 )alkyl) 3 + X − , —O—(C 10 -C 10 )alkylene-N((C 1 -C 10 )alkyl) 3 + X − , wherein X − is a counterion, at each occurrence, R L is independently chosen from a substituted or unsubstituted phenylene, thiophenylene, azulenylene, heptalenylene, biphenylene, indacenylene, fluorenylene, phenanthrenylene, triphenylenylene, pyrenylene, naphthacenylene, chrysenylene, biphenylenylene, anthracenylene, naphthylene, and -(1,4-substituted 1,4-diazabicyclo[2.2.2]octane-1,4-diium)-, and at each occurrence, L is independently chosen from a bond, —(C 1 -C 10 )alkylene-, and —O—(C 1 -C 10 )alkylene-. 13. The antimicrobial substrate of claim 10 , wherein: R 1 has the structure: at each occurrence, R 3 is independently chosen from a (C 1 -C 10 )alkylene, at each occurrence, R 4 is independently chosen from -(1,4-substituted 1,4-diazabicyclo[2.2.2]octane-1,4-diium)-R 5 , 3-R 5 -substituted-imidazolium, pyridinium,
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine · CPC title
Ionic conductors · CPC title
Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain (C08L7/00 - C08L57/00, C08L61/00 take precedence); Compositions of derivatives of such polymers · CPC title
with a five-membered ring containing one sulfur atom in the ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.